drugset / Trial / NCT01143298
LEO 27847 - Single Dose Bioavailability Study of Oral Solution Versus Tablet in Healthy Subjects
RandomizedCrossoverOpen-labelOther
Summary
The purpose of this phase 1 study is to determine the relative bioavailability following single oral dose administration of LEO 27847 solution compared to LEO 27847 tablets in healthy male subjects as well as to determine the effect of food on the single oral dose pharmacokinetics of LEO 27847 tablets in healthy male subjects.
Timeline
- Start
- 2010-06
- Primary completion
- 2010-08
- Completion
- 2010-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | LEO 27847 | Unknown | 0.01 mg | Oral |
| Subject | LEO 27847 | Unknown | 0.1 mg | Oral |
Indications
No indication recorded.